Gerstmann-Straüssler-Scheinker disease: Novel PRNP mutation and VGKC-complex antibodies

Neurology

Volumn 82, Issue 23, 2014, Pages 2107-2111

  Jones, Matthew ^a,c   Odunsi, Sola ^b   Du Plessis, Daniel ^a,b   Vincent, Angela ^d   Bishop, Matthew ^e   Head, Mark W ^e   Ironside, James W ^e   Gow, David ^a  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AXONIN 1; CONTACTIN ASSOCIATED PROTEIN LIKE 2; DNA; GLIOMA INACTIVATED PROTEIN 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; P84S PROTEIN; PREDNISOLONE; PRION PROTEIN; PROTEIN; PROTEIN ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL COMPLEX ANTIBODY;

ADULT; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ANTIBODY TITER; ANTICONVULSANT THERAPY; APATHY; ARTICLE; AUTOPSY; BLUNTED AFFECT; BRAIN TISSUE; CASE REPORT; DNA EXTRACTION; DNA SEQUENCE; DRUG TREATMENT FAILURE; DYSTONIA; ELECTROMYOGRAPHY; ENCEPHALITIS; FAMILY HISTORY; FASCICULATION; FATIGUE; FOCAL EPILEPSY; GENE MUTATION; GENETIC ASSOCIATION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; GRAY MATTER; HEMOCHROMATOSIS; HIPPOCAMPAL NEURONAL CULTURE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMOBILITY; IMMUNE MEDIATED ENCEPHALITIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LANGUAGE DISABILITY; MALE; MEDICAL RECORD REVIEW; MEMORY DISORDER; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PARANOIA; PARKINSON DISEASE; PLASMAPHERESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VISUAL DISORDER;

ANTIBODIES; ENCEPHALITIS; FATAL OUTCOME; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POTASSIUM CHANNELS, VOLTAGE-GATED; PRIONS;

EID: 84904015573     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000500     Document Type: Article

References (25)

1. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody associated encephalopathy: a potentially immunotherapy responsive form of limbic encephalitis. Brain 2004;127: 701-712.
2. Irani S, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-Associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133: 2734-2748.
3. Flanagan E, McKeon A, Lennon V, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc 2010;85: 881-897.
4. Molloy A, Cassidy E, Ryan A, O'Toole O. VGKC positive autoimmune encephalopathy mimicking dementia. BMJ Case Rep 2011;2011: bcr0820114642.
5. Geschwind M, Tan K, Lennon V, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol 2008;65: 1341-1346.
6. Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69: 892-900.
7. Head MW, Yull HM, Ritchie DL, et al. Variably proteasesensitive prionopathy in the UK: a retrospective review 1991-2008. Brain 2013;136: 1102-1115.
8. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-Associated encephalitides: clues for pathogenesis. Brain 2012;135: 1622-1638.
9. Lloyd S, Mead S, Collinge J. Genetics of prion disease. Top Curr Chem 2011;305: 1-22.
10. Jarius S, Hoffmann L, Clover L, Vincent A, Voltz R. CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis. J Neurol Sci 2008; 268: 74-77.
11. Malter MP, Elger CE, Surges R. Diagnostic value of CSF findings in antibody-Associated limbic and anti-NMDARencephalitis. Seizure 2013;22: 136-140.
12. Webb T, Poulter M, Beck J, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain 2008;131: 2632-2646.
13. Mead S, Poulter M, Beck J, et al. Inherited prion disease with six octapeptide repeat insertional mutation: molecular analysis of phenotypic heterogeneity. Brain 2006;129: 2297-2317.
14. NHLBI Exome Sequencing Project. Exome Variant Server. Available at: evs.gs.washington.edu/EVS/. Accessed February 5, 2014.
15. -1000 Genomes: a deep catalog of human genetic variation. Available at: www.1000genomes.org/home. Accessed February 5, 2014.
16. Beck JA, Poulter M, Campbell TA, et al. PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 2010;31: E1551-E1563.
17. PolyPhen-2. Prediction of functional effects of human nsSNPs. Available at: genetics.bwh.harvard.edu/pph2/. Accessed February 5, 2014.
18. Jackson GS, Murray I, Hosszu LL, et al. Location and properties of metal-binding sites on the human prion protein. Proc Natl Acad Sci USA 2001;98: 8531-8535.
19. Wong BS, Chen SG, Colucci M, et al. Aberrant metal binding by prion protein in human prion disease. J Neurochem 2001;78: 1400-1408.
20. Mackay G, Ahmad K, Stone J, et al. NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease. J Neurol 2012;259: 1979-1981.
21. Angus-Leppan H, Rudge P, Mead S, Collinge J, Vincent A. Autoantibodies in sporadic Creutzfeldt-Jakob disease. JAMA Neurol 2013;70: 919-922.
22. Grau-Rivera O, Sanchez-Valle R, Saiz A, et al. Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease. JAMA Neurol 2014;71: 74-78.
23. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-Associated disorders. Neurology 2005; 65: 1730-1736.
24. Paterson RW, Zandi MS, Armstrong R, Vincent A, Schott JM. Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry Epub 2013 Jun 11.
25. Zuliani L, Graus F, Giometto B, Bien C, Vincent A. Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 2012;83: 638-645.